Cargando…
123I‐MIBG scintigraphy and 18F‐FDG‐PET imaging for diagnosing neuroblastoma
BACKGROUND: Neuroblastoma is an embryonic tumour of childhood that originates in the neural crest. It is the second most common extracranial malignant solid tumour of childhood. Neuroblastoma cells have the unique capacity to accumulate Iodine‐123‐metaiodobenzylguanidine (¹²³I‐MIBG), which can be us...
Autores principales: | Bleeker, Gitta, Tytgat, Godelieve AM, Adam, Judit A, Caron, Huib N, Kremer, Leontien CM, Hooft, Lotty, van Dalen, Elvira C |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Ltd
2015
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4621955/ https://www.ncbi.nlm.nih.gov/pubmed/26417712 http://dx.doi.org/10.1002/14651858.CD009263.pub2 |
Ejemplares similares
-
The role of (131)I-metaiodobenzylguanidine (MIBG) therapy in unresectable and compromising localised neuroblastoma
por: Schoot, Reineke A., et al.
Publicado: (2013) -
Toxicity of upfront (131)I-metaiodobenzylguanidine ((131)I-MIBG) therapy in newly diagnosed neuroblastoma patients: a retrospective analysis
por: Bleeker, Gitta, et al.
Publicado: (2013) -
(123)I-mIBG scintigraphy in neuroblastoma: development of a SIOPEN semi-quantitative reporting ,method by an international panel
por: Lewington, V., et al.
Publicado: (2016) -
Potential Utility of (123)I-MIBG Scintigraphy as a Predictor of Falls in Parkinson's Disease
por: Murakami, Nagahisa, et al.
Publicado: (2019) -
Cardiac 123I-Metaiodobenzylguanidine (MIBG) Scintigraphy in Parkinson’s Disease: A Comprehensive Review
por: Pitton Rissardo, Jamir, et al.
Publicado: (2023)